Home » Newsletters » BioWorld Science

BioWorld Science

April 1, 1999

View Archived Issues

Aurora and Becton Dickinson announce drug development agreement

Procept receives additional patent allowances for PRO-2000

MGI Pharma to promote Ridaura and Luxiq for Connetics

DSMB completes interim evaluation of Maxamine phase III clinical trials

SciClone receives another approval for Zadaxin

Inflazyme lays plans for phase I testing of IPL-576092

Aquila initiates phase IIb testing of Quilimmune-P

New microbially produced inhibitor of HSP expression in development at Mercian

Temporary platelet inhibition by SM-20302 results in sustained antithrombotic efficacy in dog model

Xenova: year-end 1998 highlights

New microtubule-stabilizing agents developed at Schering

Dopaminergic agents for anxiety, depression and Parkinson's disease disclosed by ADIR

Merck & Co. presents new macrolide immunosuppressants

Protein farnesyltransferase inhibitors emerge from Schering-Plough/Pharmacopeia collaboration

More from ACS meeting: Pfizer presents potent new leukotriene antagonists with oral activity

New antimuscarinic piperidine derivative from Taisho inhibits bladder contractions

Dihydropyridines for reversing MDR presented at Japanese scientific meeting this week

Selective N-type VACC blockers under investigation at Warner-Lambert and Elan

First regulatory approval sought for Reminyl for Alzheimer's disease

Aronex regains worldwide marketing rights to Atragen

Popular Stories

Today's news in brief
BioWorld
IL-22 and TL1A, a robust couple for diagnosing hidradenitis suppurativa
BioWorld Science
Hidradenitis suppurativa (HS) is a chronic inflammatory skin disease with strong association with psoriasis and inflammatory bowel disease (IBD). While some...
TL1A is overexpressed in hidradenitis suppurativa
BioWorld Science
Despite the availability of advanced therapeutic options, about 40%-50% of patients with hidradenitis suppurativa do not achieve significant improvement in...
Inhibiting the NLRP3 inflammasome for cognitive impairment, stroke
BioWorld Science
Vascular cognitive impairment and dementia (VCID) and cerebral small vessel disease are among the leading causes of dementia, where inflammation is known to play...
VST Bio’s VB-001 is neuroprotector after stroke
BioWorld Science
At the recent International Stroke Conference, researchers from VST Bio Corp. and Yale University presented preclinical data regarding VB-001, a monoclonal...